(Q37085902)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278977%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278977%20AND%20SRC:MED&resulttype=core&format=json

attention deficit hyperactivity disorder

2 January 2020

main subject

0 references

0 references

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278977%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Johnny Graham

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278977%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

1 reference

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278977%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278977%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278977%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278977%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

213-237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278977%20AND%20SRC:MED&resulttype=core&format=json

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

New medications for treatment of children with attention-deficit/hyperactivity disorder: review and commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

Depression and psychotic regression following prolonged methylphenidate use and withdrawal: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

Hallucinations during methylphenidate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

Methylphenidate and growth in hyperactive children. A controlled withdrawal study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

Atomoxetine-induced hepatitis in a child.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822030-00003

Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension

21 January 2018

1 reference

12 December 2020

Relationship between psychostimulant-induced "high" and dopamine transporter occupancy

1 reference

12 December 2020

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

1 reference

12 December 2020

Stimulant therapy and seizure risk in children with ADHD.

1 reference

12 December 2020

Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation

1 reference

12 December 2020

ADHD drugs and cardiovascular risk

1 reference

12 December 2020

Severe liver injury after initiating therapy with atomoxetine in two children.

1 reference

12 December 2020

Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents

1 reference

12 December 2020

Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?

1 reference

12 December 2020

Pharmacological management of preschool ADHD.

1 reference

12 December 2020

The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and metaanalyses

1 reference

12 December 2020

Tricyclic drugs for depression in children and adolescents.

1 reference

12 December 2020

Safety profile of atomoxetine in the treatment of children and adolescents with ADHD.

1 reference

12 December 2020

Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children

1 reference

12 December 2020

Stimulant use and trichotillomania

1 reference

12 December 2020

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Successful desensitization of methylphenidate-induced rash

1 reference

12 December 2020

Methylphenidate, tics and compulsions

1 reference

12 December 2020

Cluster headache management with methylphenidate (Ritalin).

1 reference

12 December 2020

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Methylphenidate as a possible cause of thrombocytopenia

1 reference

12 December 2020

The effect of chronic methylphenidate administration on tooth maturation in a sample of Caucasian children

1 reference

12 December 2020

Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness

1 reference

12 December 2020

Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.

1 reference

12 December 2020

Lacunar stroke associated with methylphenidate abuse

1 reference

12 December 2020

Side effects of dextroamphetamine and methylphenidate in hyperactive children--a brief review

1 reference

12 December 2020

CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.

1 reference

12 December 2020

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)

1 reference

12 December 2020

Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up

1 reference

12 December 2020

Methylphenidate abuse produces retinopathy

1 reference

12 December 2020

Adderall-induced psychosis in an adolescent.

1 reference

12 December 2020

Innovations and recent trends in the treatment of ADHD.

1 reference

12 December 2020

Effects of methylphenidate (Ritalin) on mammalian myocardial ultrastructure

1 reference

12 December 2020

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

12 December 2020

Methylphenidate-induced obsessive-compulsiveness

1 reference

12 December 2020

Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment.

1 reference

12 December 2020

Bone mineral density and turnover in children with attention-deficit hyperactivity disorder receiving methylphenidate

1 reference

12 December 2020

Course of tic severity in Tourette syndrome: the first two decades

1 reference

12 December 2020

Health complaints in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Growth on stimulant medication; clarifying the confusion: a review

1 reference

12 December 2020

Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Aggression, mania, and hypomania induction associated with atomoxetine

1 reference

12 December 2020

Methylphenidate-induced mania in a prepubertal child

1 reference

12 December 2020

Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.

1 reference

12 December 2020

Attention deficit hyperactivity disorder and suicide: a review of possible associations

1 reference

12 December 2020

Clonidine and sudden death

1 reference

12 December 2020

Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial

1 reference

12 December 2020

Cardiovascular effects of atomoxetine in children, adolescents, and adults

1 reference

12 December 2020

Stimulant treatment over five years: adherence, effectiveness, and adverse effects

1 reference

12 December 2020

AACAP Official Action. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD.

1 reference

12 December 2020

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

1 reference

12 December 2020

Non-stimulant medications in the treatment of ADHD.

1 reference

12 December 2020

Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder

1 reference

12 December 2020

Clinical presentations of adult patients with ADHD

1 reference

12 December 2020

Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up

1 reference

12 December 2020

Foreword -- ADHD in the scientific and political context.

1 reference

12 December 2020

Autonomic and behavioral effects of dextroamphetamine and placebo in normal and hyperactive prepubertal boys

1 reference

12 December 2020

Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose

1 reference

12 December 2020

Increased methylphenidate usage for attention deficit disorder in the 1990s

1 reference

12 December 2020

1 reference

12 December 2020

Cerebral arteritis and oral methylphenidate

1 reference

12 December 2020

Cardiomyopathic Findings Associated With Methylphenidate

1 reference

12 December 2020

Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder

1 reference

12 December 2020

A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects

1 reference

12 December 2020

Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children

1 reference

12 December 2020

Growth deficits in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

Recent trends in stimulant medication use among U.S. children

1 reference

12 December 2020

Cytogenetic effects in children treated with methylphenidate

1 reference

12 December 2020

Absence of unfavorable effect of atomoxetine on growth in pediatric patients is still not demonstrated

1 reference

12 December 2020

Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo

1 reference

12 December 2020

Pemoline (Cylert): market withdrawal

1 reference

12 December 2020

Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy

1 reference

12 December 2020

Development of clinical services for attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder

1 reference

12 December 2020

Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

1 reference

12 December 2020

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

12 December 2020

Attention deficit disorder and epilepsy

1 reference

12 December 2020

Comparison of the clinical efficacy of twice-daily Ritalin and once-daily Equasym XL with placebo in children with Attention Deficit/Hyperactivity Disorder

1 reference

12 December 2020

Tics and Tourette's syndrome in childhood

1 reference

12 December 2020

NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines

1 reference

12 December 2020

Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache

1 reference

12 December 2020

Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.

1 reference

12 December 2020

Emerging therapies in narcolepsy-cataplexy.

1 reference

12 December 2020

Persistent amphetamine-induced compulsive rituals: response to pyridoxine(B6)

1 reference

12 December 2020

Targeting the dopamine D2 receptor in schizophrenia

1 reference

12 December 2020

Unravelling sleep problems in treated and untreated children with ADHD.

1 reference

12 December 2020

Do High Doses of Stimulants Impair Flexible Thinking in Attention-Deficit Hyperactivity Disorder?

1 reference

12 December 2020

1 reference

12 December 2020

Short term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and the classroom.

1 reference

12 December 2020

Does methylphenidate constrict cognitive functioning?

1 reference

12 December 2020

Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.

1 reference

12 December 2020

A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder

1 reference

12 December 2020

Safety and tolerability of methylphenidate in preschool children with ADHD.

1 reference

12 December 2020

Are stimulants overprescribed? Treatment of ADHD in four U.S. communities

1 reference

12 December 2020

Melatonin: prescribing practices and adverse events

1 reference

12 December 2020

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD

1 reference

12 December 2020

Mania in a boy treated with modafinil for narcolepsy

1 reference

12 December 2020

Abuse of Prescribed Stimulant Medication by a 13-Year-Old Hyperactive Boy

1 reference

12 December 2020

Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.

1 reference

12 December 2020

Methylphenidate euphoria.

1 reference

12 December 2020

Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder

1 reference

12 December 2020

Prescription of methylphenidate to children and youth, 1990-1996

1 reference

12 December 2020

A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children

1 reference

12 December 2020

Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).

1 reference

12 December 2020

PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate

1 reference

12 December 2020

Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective.

1 reference

12 December 2020

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability?

1 reference

12 December 2020

Obsessive-compulsive symptoms secondary to methylphenidate treatment

1 reference

12 December 2020

Effects of atomoxetine and methylphenidate on sleep in children with ADHD.

1 reference

12 December 2020

European clinical guidelines for hyperkinetic disorder -- first upgrade

1 reference

12 December 2020

Placebo-controlled evaluation of Ritalin side effects

1 reference

12 December 2020

Adderall and seizures

1 reference

12 December 2020

Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.

1 reference

12 December 2020

Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings

1 reference

12 December 2020

Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Experimental studies on the long-term effects of methylphenidate hydrochloride

1 reference

12 December 2020

Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary

1 reference

12 December 2020

Combining methylphenidate and clonidine: a clinically sound medication option

1 reference

12 December 2020

A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Disentangling the overlap between Tourette's disorder and ADHD

1 reference

12 December 2020

Obsessive-compulsive symptoms following stimulants.

1 reference

12 December 2020

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders

1 reference

12 December 2020

Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.

1 reference

12 December 2020

Methylphenidate hydrochloride given with or before breakfast: I. Behavioral, cognitive, and electrophysiologic effects

1 reference

12 December 2020

Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children

1 reference

12 December 2020

Psychostimulant rebound in attention deficit disordered boys

1 reference

12 December 2020

Nonstimulant medications for the treatment of ADHD.

1 reference

12 December 2020

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

12 December 2020

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

12 December 2020

Psychotic side effects of psychostimulants: a 5-year review

1 reference

12 December 2020

Use of Methylphenidate for Attention-Deficit Hyperactivity Disorder in Patients With Epilepsy or Electroencephalographic Abnormalities

1 reference

12 December 2020

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

1 reference

12 December 2020

Case study: adverse response to clonidine

1 reference

12 December 2020

How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis

1 reference

12 December 2020

The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder

1 reference

12 December 2020

Bupropion: pharmacology and therapeutic applications

1 reference

12 December 2020

Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder

1 reference

12 December 2020

Methylphenidate in children with seizures and attention-deficit disorder

1 reference

12 December 2020

Cerebral vasculitis following oral methylphenidate intake in an adult: a case report

1 reference

12 December 2020

Hemodynamic effects of acute administration of atomoxetine and methylphenidate

1 reference

12 December 2020

Tourette's syndrome: are stimulants safe?

1 reference

12 December 2020

Fixed drug eruption of the scrotum due to methylphenidate

1 reference

12 December 2020

Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder

1 reference

12 December 2020

Methylphenidate and idiopathic thrombocytopenic purpura--is there an association?

1 reference

12 December 2020

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Methylphenidate Hallucinosis

1 reference

12 December 2020

Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivity

1 reference

12 December 2020

Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children

1 reference

12 December 2020